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Objective: To investigate the effectiveness of a patient education (PE) program with or without the added
effect of manual therapy (MT) compared to a minimal control intervention (MCI).
Methods: In a single-center university hospital setting, a total of 118 patients with clinical and
radiographic unilateral hip osteoarthritis (OA) from primary care were randomized into one of three
groups: PE, PE plus MT or MCI. The PE was taught by a physiotherapist involving ﬁve sessions. The MT
was delivered by a chiropractor involving 12 sessions and the MCI included a home stretching
program. Primary outcome was self-reported pain severity on an 11-box numeric rating scale (NRS)
immediately following a 6-week intervention period. Patients were followed for 1 year.
Results: Primary analysis included 111 patients (94%). In the combined group (PE þ MT), a clinically
relevant reduction in pain severity compared to the MCI of 1.90 points (95% conﬁdence interval (CI)
0.9e2.9) was achieved. Effect size (Cohen’s d) for the PE þ MT minus the MCI was 0.92 (95% CI
0.41e1.42). Number needed to treat for PE þ MT was 3 (95% CI 2e7). No difference was found be-
tween the PE and MCI groups, with mean difference 0.0 (95% CI 1.0 to 1.0). At 12 months, not
including patients receiving hip surgery the statistically signiﬁcant difference favoring PE þ MT was
maintained.
Conclusions: For primary care patients with OA of the hip, a combined intervention of MT and PE was
more effective than a MCI. PE alone was not superior to the MCI.
Trial registration: clinicaltrials.gov NCT01039337.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Hip osteoarthritis (OA) is a common joint disease and when
symptomatic can have signiﬁcant impact on regular daily activ-
ities1. Recently, hip OA has been linked to higher mortality rates2. In
end stage hip OA, joint replacement surgery is an appropriate and
cost-effective treatment3,4 but a long-term cohort study hasE. Poulsen, Nordic Institute of
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nsen), eroos@health.sdu.dk
Vach), soeren.overgaard@
s Research Society International. Pdocumented that only 20% of patients with radiographic hip OA
have had surgery 11e28 years after the initial diagnosis5. Therefore,
non-surgical interventions with documented effectiveness become
essential for patients who do not need, or choose not to have,
surgery.
In Denmark, there is no consensus around standardized mini-
mal care for hip OA patients in primary care and standardized pa-
tient education (PE) programs are not available to the public. In
other countries, PE programs have been developed for OA patients
to improve self-management through understanding of the disease
and change of health behavior6. Although guidelines recommend
PE programs as a core intervention7, systematic reviews are con-
tradictory in conclusions regarding their effectiveness on pain and
function8,9.ublished by Elsevier Ltd. All rights reserved.
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vention to exercise for patients with hip OA7,10 but evidence is
based on a single randomized clinical trial (RCT)11.
MT is offered infrequently in Denmark for hip OA patients and is
likely to be dependent on clinician or therapist preference and skill.
Given the limited number of trials dealingwith PE andMT for hipOA
to date, this study aimed to examine the feasibility of a trial set-up
and investigate if the chosen outcome measures were responsive
in patients with hip OA from primary care in Denmark. Therefore,
the current trial was designed as a proof-of-principle trial to inform
the design of future RCTs involving PE and MT by investigating the
effectiveness, in terms of pain reduction, of a PE program with or
without the added effect of MT compared to a minimal control
intervention (MCI) involving home stretching. The secondary aim
was to explore the effect of adding MT to PE.
Methods
Study design and participants
The design was a single-center proof-of-principle three-arm
parallel group RCT. Patient characteristics, recruitment procedures,
exclusion criteria, follow-up time points and blinding procedures
have been described in the published protocol12. Inclusion criteria
were1 Unilateral hip pain >3 months’ duration2, Age 40e80
years3, Radiographic hip OA deﬁned as minimal joint space width
(JSW) measurement <2.00 mm13 or a side difference in minimal
JSW >10%, and4 Ability to speak and read Danish. Recruitment,
clinical examinations and treatment all took place at the Depart-
ment of Orthopaedic Surgery and Traumatology, Odense Univer-
sity Hospital, Denmark. The study was carried out according to the
Helsinki Declaration and approved by the Regional Ethics Com-
mittee of Southern Denmark (approval number S-20080027) and
the Danish Data Protection Agency (J.nr.2008-41-1910). Patients
received written and oral information and signed an informed
consent form.
During the ﬁrst 2months of recruitment, three exclusion criteria
were added to the original criteria1: patients who had had MT
within the previous twelve months2; patients who rated their pain
severity as 1 or 2 on the primary outcome 11-box numerical
rating scale (NRS), since improvement would not be measurable3;
patients with polyarthritis, deﬁned as having OA-like symptoms
from more than three anatomic areas.
Randomization
Patients were randomized to one of three groups: a PE program;
the PE program plus MT; or the MCI. The randomization sequence
with block sizes of three, six or nine was computer generated by a
person not otherwise involved in the study and envelopes were
generated by yet another person not otherwise involved in the trial.
To allow for patient interaction in the PE groups, a minimum of 10
patients had to be eligible to enter the study ensuring a minimum
of three patients for each of the two groups involving PE. Therefore,
patients would wait from the time of eligibility until the day
scheduled for the allocation procedure. On the day of allocation, a
number of sealed opaque envelopes matching the number of pa-
tients scheduled were generated and each patient selected an en-
velope following completion of patient-reported outcome
measures. The envelope was opened in front of the project nurse
and allocation was made to the appropriate group. If allocationwas
to the MCI group, the nurse provided written advice on a home
stretching program derived from the PE program together with a
5e10-min instruction. The project nurse was not involved in the
assessment of patients.Interventions
Protocols for the PE program, MT and MCI are attached in
Appendix 1. The PE program, originally termed ‘Hip School’14 was
taught by a physiotherapist with 11 years’ experience in orthopedic
hospital departments involving aspects of PE and rehabilitation.
The therapist received special training teaching the program prior
to the study. The PE program included two individual sessions and
three group sessions. The MT was administered by the ﬁrst author
(EP), a chiropractor with 20 years of clinical experience and 10
years of speciﬁc clinical and research interest in patients with hip
OA. MT was scheduled twice a week for the 6-week intervention
period and treatment was individualized to each patient depending
on examination ﬁndings (Appendix 1). Instructions for the home
stretching program were given by the project nurse who had 10
years of experience with orthopedic patients.
Outcome measures
The primary outcome was pain severity rated on an 11-box NRS,
measured after 6 weeks of intervention. Patients were asked to rate
the worst pain experienced during the previous week. The scale is
recommended and documented as reliable, valid and responsive in
chronic pain patients15,16.
The original protocol registered with clinicaltrials.gov
(NCT01039337) listed two primary outcomes: pain severity and
physical function. Due to CONSORT recommendations and to avoid
multiplicity of analysis, pain severity was selected as the sole pri-
mary outcome a priori before completing the trial and before
accessing the data, as published in the study protocol12.
Secondary outcome measures were the Hip disability and
Osteoarthritis Outcome Score (HOOS) range 0e100, worst to best;
patients’ perceived global effect of interventions, percentage in
each group having classiﬁed themselves as improved; passive hip
range of motion (ROM); use of pain medication at 12 months and
hip replacement surgery within the 12 month follow-up period.
Both HOOS and patients’ perceived global effect of interventions
are considered valid and responsive in patients with musculo-
skeletal conditions17,18. Hip ROM was measured following a stan-
dardized protocol. The outcome assessor was a physiotherapist not
otherwise involved in the assessment or treatment of patients. A
reproducibility study of the ROM measurements was conducted
involving 51 patients. The intraclass correlation coefﬁcient
(ICC1.0)19 ranged from 0.73 to 0.93 with narrow 95% conﬁdence
intervals (CIs) and standard error of the measurements (SEMagree-
ment)20 ranging between 1.1 and 6.1. The variables ‘use of pain
medication’ and ‘hip surgery’ at 12-month follow-up were dichot-
omized into yes/no. ‘Pain medicationwas dichotomized into yes/no
as less than 50% of patients at baseline listed usage of pain medi-
cation. At baseline patients in all three groups were instructed not
to change their pain medication if at all possible making dose
calculation highly unreliable. Further, reporting was hampered
because patients could not remember name or dosage of medica-
tion. The protocol paper lists EuroQoL-5D and a patient speciﬁc
functional scale (PSFS) as secondary outcome measures. They are
planned to be reported separately.
Follow-up time points and blinding
Baseline questionnaires including primary and secondary out-
comes were completed at the university hospital on the day of
randomization and were repeated after 6 weeks and 3 and 12
months. They were mailed to patients prior to the appointment for
the physical examination andwere returned in a sealed envelope to
the examination assessor, who performed all examinations at all
E. Poulsen et al. / Osteoarthritis and Cartilage 21 (2013) 1494e15031496time points. Patients were instructed not to reveal group allocation
to the assessor, but blinding was not conﬁrmed for all patients.
Adverse events
A standardized questionnaire was used to assess adverse re-
actions in all groups including questions on location, severity,
onset, duration, and inﬂuence on activities of daily living (ADL).
Patients were asked at the last sessions in the PE and PE þ MT
groups whereas the MCI group was interviewed by a secretary by
phone immediately after the 6 weeks intervention period. Adverse
events were only collected for the last 50% of patients completing
the trial since the beneﬁt of assessing adverse events information
was recognized half way into the trial.
Sample size
In patients with hip OA, the minimal clinically important
improvement for pain is estimated to be 15 points on a 0e100
scale21. Using a conservative estimate, we aimed at demonstrating a
statistically signiﬁcant difference of 17 points on the primary
outcome after treatment with a 5% signiﬁcance level and 80% po-
wer between the group of PE vs MCI or PE þ MT vs MCI. Thus, 30
patients were to be included in each group assuming a joint normal
distribution for baseline and 6-week follow-upwith a correlation of
0.3 and equal variances. Allowing for a 15% drop out, it was decided
to include a minimum of 106 patients.
Statistical analyses
Double data entry was done by a research assistant not
otherwise participating in the study. The study population were all
patients randomized, excluding those where violations of the in-
clusion criteria was detected after randomization. Patients with-
drawn prior to the 6 weeks follow-up were described and
compared to the other patients, but excluded in the main analyses.
Otherwise, the main analyses followed the intention-to-treat
principle analyzing all patients “as randomized” including those
who received hip surgery between 6 weeks and 12 months12. In
addition, a per-protocol analysis was performed for the 12 month
data excluding patients having had hip replacement. The primary
statistical analysis was performed with respect to the change over
the 6-week intervention period where the largest treatment effect
was expected. In the planning of the study only the comparisons
PE vs MCI and PE þ MT vs MCI with respect to the main outcome
were considered as conﬁrmative, and the comparison PE vs
PE þ MT was considered as explorative. The overall group differ-
ences in pain severity were analyzed using analysis of covariance
(ANCOVA) with adjustment for baseline values with a signiﬁcance
level of 0.05. The pre-speciﬁed pair-wise comparisons between
the two active treatments and the MCI were analyzed using
Dunnett’s procedure ensuring a global signiﬁcance level of 0.05,
which does not require the ANCOVA omnibus test to be signiﬁ-
cant22. Effect sizes were computed by dividing the effect estimates
from the ANCOVA by the pooled standard deviation (SD) of the
baseline values. The number needed to treat (NNT) was calculated
for each of the active treatment groups in comparison to the MCI
including 95% CIs (if statistically signiﬁcant). The NNT estimates
the number of patients who need to undergo treatment in order
for one patient to experience a pain reduction of at least 25% from
baseline to 6 weeks. A secondary exploratory analysis of the dif-
ference between the PE group and PE þ MT was performed using
Bonferroni corrected ANCOVA. The secondary statistical analysis
included the same approach as described above for all the sec-
ondary outcomes involving continuous data.A longitudinal analysis of the primary and secondary outcomes,
incorporating data from baseline, 6 weeks, 3 months and 12
months, was conducted using a linear mixed model approach. The
P-values of the two comparisons with the MCI group were again
based on Dunnett’s procedure. Binary outcomes, use of pain
medication and hip surgery at 12 months, were analyzed by pair-
wise application of Fisher’s exact test. Effect sizes reporting
Cohen’s d including 95% CIs are displayed for the comparisons: PE
andMCI, PEþMTandMCI, PE and PEþMT. Due to the low number
of drop outs, a decision was made not to use the multiple impu-
tation model for missing data as described in the protocol.
Patients’ perceived global effect of interventions was catego-
rized into (1) improved (patients responding with ‘better’ or ‘much
better’) and (2) no change (other response options). Statistical
software used for analyses was Stata 12 (StataCorp, Texas, USA).
Results
From December 2008 to May 2010, 331 patients were screened
and recruitment ended when 118 eligible patients had been ran-
domized. Patient ﬂow through the study is illustrated in Fig. 1. Two
hundred and eighty-eight were referred from general practitioners,
22 from chiropractors, 15 by orthopedic surgeons and six patients
contacted the project directly. Two hundred and thirteen were not
eligible to enter the trial; the reasons being listed in Appendix 2.
After randomization but on the same day, four patients previously
found eligible were excluded: three presented with bilateral hip
pain and one with lower leg neuropathy. At the ﬁrst appointment
for MT, three previously randomized patients were excluded: one
did not have clinical signs of hip OA and two presented with pol-
yarthritis. In order not to disrupt the sequence of randomization,
each letter for the seven who had been excluded was re-entered
into the sequence and thus, a total of 111 patients were included
in the analyses at the primary end point at 6 weeks. Patient char-
acteristics at baseline are presented in Table I. Of the 71 patients
from the two groups receiving PE, 10 missed one group session, one
missed two sessions and four missed the second personal inter-
view. Thirty-ﬁve patients participated in the MT intervention: 33
participated in all 12 sessions, one participated in 11 sessions and
one withdrew after seven sessions.
At 6 weeks follow-up, nine patients (8.1%) had withdrawn. In
the PE group, one withdrew due to lack of commitment. In the
PEþMTgroup, four withdrew: one felt the treatment was too time-
consuming, one wanted hip surgery, one had surgery for another
unrelated health reason and one became worse from the MT. The
mean age of patients withdrawing was 71.8 years (SD 3.3) and pain
severity at baseline on the NRS score was 5.8 (SD 2.2). In the MCI
group, three were discontented with the group allocation and one
wanted hip surgery. The mean age of patients withdrawing was
63.2 years (SD 11.0) and pain severity on the NRS score was 6.5 (SD
1.7). At 3months, one patient from the PE group (0.9%) had received
hip surgery (3 months data missing) and between 3 and 12months,
20 (18%) had received hip surgery. Mean scores of NRS, HOOS and
ROM at baseline, 6 weeks, 3 and 12 months for the three groups are
listed in Appendix 3.
Primary outcome
Mean change scores including SDs from baseline to 6-week
follow-up are presented in Table II and group differences with
95% CIs and effect sizes including 95% CIs are listed in Table III.
At the primary end point (6 weeks), no overall statistically sig-
niﬁcant differences were found between all three groups for mean
pain severity (PE: 5.3 [SD 2.3], PE þ MT: 3.4 [2.4], MCI: 5.3 [1.7]
P ¼ 0.058). For the pair-wise comparison, the PE þ MT group
331 patients assessed for eligibility
143 had clinical and radiological examination
325 contacted by phone
118 were randomized
182 excluded*
15 not meeting inclusion criteria
148 meeting exclusion criteria
7 not wanting to participate
12 due to other reasons
25 excluded*
22 not meeting inclusion criteria
3 due to other reasons
39 assigned to 
patient education (PE)
37 assessed at baseline
36assessed at 12 months
5 excluded
1 had bilateral hip pain
2 had polyarthritis
1 did not have hip OA
1 had leg neuropathy
38 assessed at baseline
34 assessed at 6 weeks36 assessed at 6 weeks 32 assessed at 6 weeks
34 assessed at 12 months 32 assessed at 12 months
6 not included due to late referral
36 assessed at baseline
36 assigned to 
minimal control intervention
2 excluded due to 
bilateral hip pain
1 withdrew due to 
lack of commitment
43 assigned to 
PE and manual therapy
4 withdrew
1 had surgery (not hip)
1 wanted operation
1 due to time constraint
1 got worse from MT
4 withdrew
3 disappointed with group
1 wanted operation
1 had arthroplasty
11 had arthroplasty 3 had arthroplasty 6 had arthroplasty
35 assessed at 3 months 34 assessed at 3 months 32 assessed at 3 months
Fig. 1. Chart of patient recruitment and randomization. Primary end point indicated at 6 weeks. *Excluded patients are speciﬁed in Appendix 2. Shaded area indicates primary end
point for primary outcome.
E. Poulsen et al. / Osteoarthritis and Cartilage 21 (2013) 1494e1503 1497achieved a 1.9 points greater pain reduction compared to the MCI
(95% CI 0.9e2.9). No difference was found between the PE and MCI
groups (95% CI 1.0 to 1.0). Effect size for the PE þ MT minus the
MCI group was 0.92 (95% CI 0.41e1.42) and for the PE minus the
MCI group, 0.02 (0.49 to 0.46). The number of patients in each
group experiencing pain reduction of at least 25% from baseline to 6
weeks was PE¼ 8, PEþMT¼ 21 and MCI¼ 7. The NNT for PE þMT
vs MCI was 3 (95% CI 2e7).
Secondary outcomes at 6 weeks
Differences between all three groups were signiﬁcant for the
HOOS subscales Pain (P ¼ 0.021), Function in sport and recreation
(Sport/Rec.) (P ¼ 0.022) and Hip-related quality of life (QoL)
(P ¼ 0.040) but not for the subscales of Symptoms (P ¼ 0.095) and
Function in daily living (ADL) (P ¼ 0.060). All HOOS subscales
demonstrated clinically relevant and statistically signiﬁcant supe-
riority, P < 0.05 for the PE þMT group when compared to the MCIgroup: 17 points (95% CI 11e23) for Pain; 13 points (5e20) for
Symptoms; 14 points (7e22) for ADL; 17 points (8e25) for Sport/
Rec.; and 13 points (6e20) for QoL. Mean differences between PE
and MCI were small (range 4 to 1) and not statistically signiﬁcant,
P > 0.05. Effect sizes for HOOS subscales for PE þ MT minus MCI
ranged between 0.75 and 1.08. For ROM measurements, neither
overall nor pair-wise comparisons were statistically signiﬁcant.
Mean change scores including SDs from baseline to 6-week follow-
up are presented in Table II. Group differences with 95% CIs and
effect sizes including 95% CIs are listed in Table III.
Exploratory analysis of difference between PE and PE þ MT groups
at 6 weeks
The PE þ MT group was able to reduce pain severity with a
clinically relevant difference of 1.9 points compared to PE alone,
95% CI (0.8e2.9). The same pattern was demonstrated for all HOOS
subscales. No difference between groups was found for ROM
Table II
Change scores from baseline to 6 weeks and 12months. As randomized (ar) and per-
protocol (pp) analyses are presented for the change scores at 12 months. Means (SD)
Variable PE PE þ MT MCI
NRS pain
6 Weeks 0.3 (1.9) 1.9 (2.3) 0.3 (1.5)
12 Months (ar) 1.5 (3.6) 1.8 (3.1) 1.5 (2.6)
12 Months (pp) 0.5 (2.3) 1.2 (2.7) 1.0 (2.0)
HOOS pain
6 Weeks 1 (11) 18 (13) 3 (13)
12 Months (ar) 11 (23) 16 (20) 13 (18)
12 Months (pp) 3 (13) 13 (19) 8 (11)
HOOS symptoms
6 Weeks 1 (15) 15 (15) 4 (11)
12 Months (ar) 10 (23) 12 (19) 10 (18)
12 Months (pp) 2 (17) 9 (16) 8 (13)
HOOS function in daily living
6 Weeks 1 (10) 15 (16) 5 (13)
12 Months (ar) 9 (21) 13 (20) 10 (18)
12 Months (pp) 3 (13) 10 (19) 7 (13)
HOOS sport and recreation
6 Weeks 2 (14) 21 (18) 11 (18)
12 Months (ar) 10 (21) 13 (22) 11 (22)
12 Months (pp) 1 (16) 11 (22) 7 (19)
HOOS hip-related QoL
6 Weeks 2 (11) 12 (18) 4 (10)
12 Months (ar) 10 (27) 10 (20) 12 (21)
12 Months (pp) 4 (18) 6 (17) 6 (13)
ROM e ﬂexion
6 Weeks 1 (11) 6 (15) 3 (7)
12 Months (pp) 1 (12) 5 (16) 2 (10)
ROM e abductioneadduction
6 Weeks 1 (6) 3 (7) 1 (8)
12 Months (pp) 4 (5) 3 (8) 1 (8)
ROM e internaleexternal rotation
6 Weeks 3 (9) 2 (13) 4 (12)
12 Months (pp) 0 (9) 4 (11) 0 (11)
HOOS¼ hip osteoarthritis disability and osteoarthritis outcome score; ROM ¼ range
of motion.
Table I
Characteristics at baseline for patients with unilateral hip OA
Variable PE PE þ MT MCI
Number of patients per group 37 38 36
Age in years, mean (SD) 65.5 (7.3) 65.8 (8.5) 62.5 (9.4)
Female gender, n (% within group) 14 (38) 17 (45) 17 (47)
Body mass index (BMI) (kg/m2),
mean (SD)
27.4 (3.4) 26.3 (3.6) 26.7 (4.2)
Involved side right/left (n) 17/20 26/12 24/12
Duration of symptoms in months,
mean (SD)
32 (25) 26 (26) 37 (50)
Range (months) 6e96 4e120 4e300
Minimal JSW for involved joint (mm)
mean (SD)
1.46 (1.11) 1.56 (1.05) 1.61 (1.11)
Minimal JSW <2.00 (n) 26 27 23
Minimal JSW side difference > 25% (n) 9 10 9
Minimal JSW side difference <25% and >
10% (n)
2 1 4
Worst pain experience, 11-box NRS
(0e10), mean (SD)
5.1 (2.0) 5.4 (2.4) 5.8 (1.6)
HOOS pain, mean (SD) 64 (14) 62 (17) 58 (14)
HOOS symptom, mean (SD) 62 (17) 61 (18) 59 (15)
HOOS function of daily living, mean (SD) 68 (15) 68 (20) 64 (15)
HOOS sport and recreation, mean (SD) 53 (22) 55 (21) 49 (21)
HOOS hip-related QoL, mean (SD) 53 (18) 52 (17) 46 (12)
Flexion ROM (), mean (SD) 106 (14.8) 105 (13.8) 109 (12.6)
Abductioneadduction ROM (),
mean (SD)
41 (8.2) 41 (8.2) 42 (8.8)
Internaleexternal rotation ROM (

),
mean (SD)
64 (15.2) 65 (13.8) 65 (11.8)
Pain medication, n (% within group) 20 (54) 16 (42) 15 (42)
Employed (n) 12 14 18
Unemployed (n) 0 0 1
Retired (n) 24 24 17
Health-related pension (n) 1 0 0
Current sick leave due to the hip (n) 0 0 1
Source of recruitment
General practitioner, n (% within group) 33 (89.2) 31 (81.6) 30 (83.3)
Chiropractor, n (% within group) 3 (8.1) 5 (13.2) 4 (11.1)
Orthopedic surgeon, n (% within group) 0 0 1 (2.8)
Self-referral, n (% within group) 1 (2.7) 2 (5.3) 1 (2.8)
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including 95% CIs are listed in Table IV.
Pair-wise comparison between PE and MCI and PE þ MT and MCI
including all time points
When applying Dunnett’s procedure to the linear mixed model,
none of the outcome measures demonstrated statistically signiﬁ-
cant or clinically relevant differences between any of the two active
interventions and the MCI. Applying the same analyses and
excluding patients having received hip replacement surgery (per-
protocol analysis), the combined PE þ MT group had reduced pain
severity on the NRS with 1.1 points (0.1e2.1), P ¼ 0.026, compared
to the MCI group and all HOOS subscales improved in the PE þMT
group in comparison to the MCI group demonstrating statistically
signiﬁcant changes (Table III). Mean change scores and SDs from
baseline to 12 months for both as randomized and per-protocol
analyses are presented in Table II. Group differences with 95% CIs
incorporating all time points are presented in Table III. Mean scores
and SDs for NRS pain severity for the three groups at all time-points
incorporating the as randomized and per-protocol analyses are
presented in Fig. 2(A and B).
Patients’ perceived global effect of intervention
At 6 weeks, 76.5% of patients in the PEþMTgroup had classiﬁed
themselves as improved compared to 22.2% in the PE group and
12.5% in the MCI group, P < 0.001.Use of pain medication at 12 months was not statistically
signiﬁcantly different for the pair-wise comparisons (PE ¼ 23,
PE þMT ¼ 10, MCI ¼ 14) and there was no difference between the
three groups with respect to hip surgery (PE ¼ 12, PE þ MT ¼ 4,
MCI ¼ 7), P ¼ 0.071. Patients having received hip surgery were
signiﬁcantly worse at baseline for pain severity (P ¼ 0.003), dura-
tion of symptoms (P ¼ 0.029) and use of medication (P ¼ 0.002)
when compared to patients not having had surgery.Adverse reactions or unintended effects
Data on adverse reactions were collected for the last 63
consecutive patients included. The PE group reported no adverse
events. In the PE þ MT group, seven patients reported discomfort,
muscle soreness or mild pain appearing up to 24 h after MT, lasting
for no more than 24 h and not affecting ADL. One patient reported
moderate pain appearing after 4 weeks of therapy, lasting for 2
weeks, and having some effect on ADL. In the MCI group, two pa-
tients reported worsening of hip pain following home stretches.
The pain lasted for more than 2 days and had a moderate effect on
ADL. Both patients stopped the speciﬁc home stretches.Discussion
This RCT successfully demonstrated differences in short-term
outcomes when comparing a combined PE and MT intervention
to a MCI in patients with hip OA referred from primary care. Even
with small group sizes, the combined PE and MT intervention
demonstrated a clinically relevant pain reduction and
Table III
Group differences of mean change scores incl. 95% CIs at 6 week and 12 months for PE vs MCI and PE þMT vs MCI. Group differences at 12 months list as randomized and per-
protocol analyses. Effect sizes (Cohen’s d) based on ANCOVA analysis incl. 95% CIs at 6 weeks
Variable Difference, PE vs
MCI (95% CIs)
Effect size (95% CIs) Difference, PE þ MT vs
MCI (95% CIs)
Effect size (95% CIs)
NRS pain
6 Weeks 0.0 (1.0 to 0.9) 0.02 (0.49 to 0.46) 1.9 (2.9 to 0.9) 0.92 (1.42 to 0.41)
12 Months (ar) 0.5 (2.0 to 0.9) 0.5 (1.9 to 0.9)
12 Months (pp) 0.1 (1.1 to 0.9) 1.1 (2.1 to 0.1)
HOOS pain
6 Weeks 0.7 (6 to 7) 0.01 (0.47 to 0.49) 17 (11e23) 1.08 (0.56e1.59)
12 Months (ar) 3 (7 to 13) 6 (4 to 16)
12 Months (pp) 2 (6 to 9) 10 (3e18)
HOOS symptoms
6 Weeks 2 (10 to 5) 0.13 (0.61 to 0.34) 13 (5e20) 0.75 (0.25e1.25)
12 Months (ar) 2 (8 to 12) 3 (7 to 13)
12 Months (pp) 1 (9 to 8) 8 (0e16)
HOOS function in daily living
6 Weeks 0 (7 to 6) 0.05 (0.53 to 0.42) 14 (7e20) 0.85 (0.34e1.36)
12 Months (ar) 3 (7 to 13) 6 (4 to 16)
12 Months (pp) 1 (8 to 9) 9 (1e17)
HOOS sport and recreation
6 Weeks 4 (12 to 4) 0.20 (0.67 to 0.28) 17 (8e25) 0.87 (0.36e1.37)
12 Months (ar) 4 (7 to 15) 8 (2 to 19)
12 Months (pp) 1 (11 to 9) 12 (2e22)
HOOS hip-related QoL
6 Weeks 1 (6 to 7) 0.04 (0.44 to 0.52) 13 (6e20) 0.88 (0.37e1.38)
12 Months (ar) 4 (7 to 14) 6 (5 to 18)
12 Months (pp) 3 (5 to 11) 10 (2e17)
ROM e ﬂexion
6 Weeks 7 (12 to 1) 0.54 (1.03 to 0.04) 3 (9 to 2) 0.26 (0.75 to 0.23)
12 Months (pp) 5 (11 to 2) 3 (8 to 3)
ROM e abductioneadduction
6 Weeks 2 (6 to 1) 0.29 (0.77 to 0.20) 2 (1 to 5) 0.25 (0.25 to 0.74)
12 Months (pp) 1 (5 to 3) 1 (3 to 5)
ROM e internaleexternal rotation
6 Weeks 4 (10 to 2) 0.29 (0.78 to 0.20) 4 (11 to 2) 0.28 (0.78 to 0.22)
12 Months (pp) 3 (10 to 4) 0 (7 to 7)
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when compared to the control group receiving a minimal inter-
vention of home stretching. No difference was found when
comparing PE alone to the minimal intervention.
The ﬁnding of pain reduction and improvement in all of the
HOOS subscales in the group receiving PE þ MT may have several
explanations. First, the physical components of the MT are a
possible contributor to the effect23. In trials including MT with
documented effectiveness, the consistent component is joint
manipulation (forceful traction). Hoeksma et al. demonstrated MT
including manipulation to be superior to exercise therapy in pa-
tients with hip OA24, Vaarbakken and Ljunggren reported results
similar to ours when comparing forceful traction to standard
traction mobilization in patients with hip disability25 and Abbott
et al. has recently demonstrated MT including thrust techniques
(forceful traction) being superior to usual care26. AmongTable IV
Differences of mean change scores incl. 95% CIs and effect sizes (Cohen’s d) incl. 95%
CIs at 6 weeks between PE and PE þ MT
Variable Difference, PE vs
PE þ MT (95% CIs)*
Effect size (95% CIs)
NRS pain 1.9 (2.9 to 0.8) 0.79 (0.30e1.27)
HOOS pain 16 (10e23) 0.97 (0.47e1.46)
HOOS symptoms 15 (7e23) 0.82 (0.33e1.30)
HOOS function in daily living 14 (7e21) 0.84 (0.34e1.32)
HOOS sport and recreation 21 (12e30) 0.94 (0.45e1.44)
HOOS hip-related QoL 12 (5e20) 0.72 (0.23e1.20)
ROM e ﬂexion 4 (2 to 9) 0.28 (0.20 to 0.75)
ROM e abductioneadduction 4 (0e8) 0.53 (0.04e1.00)
ROM e internaleexternal rotation 0 (6 to 7) 0.01 (0.49 to 0.46)
* Bonferroni corrected ANCOVA.practitioners of MT, manipulation is by deﬁnition different to
mobilization27,28. The difference between the two is the force
generated and studies on patients with hip OA using standard
mobilization techniques have not demonstrated effectiveness
when compared to forceful traction/manipulation24,25. Second, the
combined intervention group received 12 more sessions than the
PE alone group and 17 more sessions than the MCI group, intro-
ducing the risk of attention bias29 but the studies by Hoeksma
et al.24 and Vaarbakken & Ljunggren25 both controlled for attention
and demonstrated signiﬁcant improvement when forceful traction/
manipulation was applied in comparison to non-forceful traction/
mobilization. Third, the placebo effect is a possible explanation. In a
meta-analysis of drug trials, Zhang et al. have reported an effect size
of 0.37 (95% CI 0.21e0.53) for pain reduction in hip OA patients
receiving placebo treatment30. The lack of statistical signiﬁcance for
the difference observed at 12months is probably due to the positive
outcome after hip replacement surgery. Indeed, the per-protocol
analyses demonstrate clinically relevant and statistically signiﬁ-
cant differences for all patient-reported outcomes in favor of the
PE þ MT group at 12 months.
No differences were found between the PE and MCI groups at
any follow-up. This is in accordance with conclusions from a meta-
analysis from 2005 on the effectiveness of PE programs for hip and
knee OA patients and subsequent studies demonstrating little or
no effect on pain and function of self-management or PE programs
for patients with arthritis8,31e34. Inclusion of a MCI was based on
no minimal intervention is currently standard for hip OA patients
in Denmark and a home program in the form of a leaﬂet is com-
mon at time of ﬁrst diagnosis. Further, this particular PE program
has not been compared to a minimal non-pharmacological
intervention.
AB
Fig. 2. Pain severity on an 11-box NRS at baseline, 6 weeks, 3 and 12 months including
SDs. A. as randomized. B. per-protocol. *PE ¼ patient education, MT ¼manual therapy,
MCI ¼ minimal control intervention.
E. Poulsen et al. / Osteoarthritis and Cartilage 21 (2013) 1494e15031500These results should be interpreted in the light of several potential
limitations. First, we included patients with minimal JSW difference,
deﬁnedas>10%and<25%,which iswithin the limits ofmeasurement
error. But due to randomization and equal distribution of the seven
patients with minimal JSW difference between the three treatment
groups, we consider the inﬂuence minimal. Second, performance-
based measures of physical function are recommended as second-
ary outcomes in hip and knee OA research but were not incorporated
in this study due to practical and logistical issues35,36. Third, the
recruitment processwasnot optimal resulting in sevenpatients being
excluded post-randomization but before initiation of treatment,
however this is unlikely to have caused bias37. Fourth, because our
studywasnot powered to compare thePE and PEþMT interventions,
our main results could formally not be tested in a conﬁrmative
manner. Lastly, the PE and MT were administered by only one thera-
pist/chiropractor, limiting the external validity.
Overall, our study was able to demonstrate that also in
Denmark with little experience in using PE and MT for OA pa-
tients, it is possible to conduct RCTs able to demonstrate relevant
differences between non-surgical non-pharmacological in-
terventions. Therefore, we consider our current framework a
useful tool in planning future studies including larger cohorts
allowing investigations of more subtle differences between rele-
vant treatment options. Future trials should consider the
following: (1) MT should be compared to PE alone and the optimal
frequency and dose of MT should be determined; (2) inclusion ofpatients with co-morbidities and multiple sites of symptomatic
OA to improve generalizability; (3) more than one therapist
should deliver the MT and PE.
We suggest that patients currently receiving MT for hip OA in
primary care should be informed about possible short-term discom-
fort, muscle soreness or mild pain lasting up to 48 h following MT.
In conclusion, this proof-of-principle trial was able to demon-
strate clinical and statistically signiﬁcant differences between a
combined intervention consisting of MT and PE when compared to
a MCI including home stretching for both primary (pain) and sec-
ondary outcomes in patients with unilateral hip OA. PE alone was
no different to a MCI in reducing pain.
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Appendix 1. Protocols for PE, MT and MCI
Patients in all three groups receive instruction not to initiate or
alter use of pain medication or use of glucosamine products during the
6-week intervention period.
PE
The PE program was taught by a physiotherapist, who had
received speciﬁc training for teaching this program. It is designed
by Maria Klässbo and the original text and illustrations are trans-
lated into Danish with permission14.
Reason for exclusion (n)
Not meeting inclusion criteria 37
- Age <40 or >80 years 12
- Duration of hip pain <3 months 2
- No radiographic OA 22
- Not able to read or write Danish 1
Meeting exclusion criteria 148
- Bilateral hip pain 45
(continued on next page)
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interview, three group sessions and one follow-up interview. Power
point presentations and anatomic models are used as teaching aids.
Each patient receives a sheet of paper with recommendations for
activities of daily living (ADL) and home stretching exercises related
to balance and hip mobility.
Initial interview (45 min)
The aim of the interview is to assist the therapist to understand
the condition from the patient’s viewpoint including pain experi-
ence, inﬂuence on ADL and levels of self-motivation. Ranges of
reduced hip mobility and levels of coordination and balance are
assessed for targeting speciﬁc exercises.
Group sessions
The purpose of group sessions is to create interaction between
patients and have them share their individual experiences.
Group session 1 (1½ h)
Hip anatomy is taught including the purpose of cartilage, bone,
joint capsule, ligaments, muscles and blood supply. Basic epide-
miology includes age and gender distribution, risk factors and
natural course of the disease. Diagnosis of hip OA clinically and
radiographically is explained.
Group session 2 (1½ h)
The session is initiated by a short review. Hip muscle action, in-
ﬂuence of locomotion and hip mobility on maintaining a healthy
joint aswell as howOAaffectsmuscle function, ROMandmovement
are explained. Advice is given on keeping an active lifestyle and
activities like swimming, cycling and walking are recommended.
Group session 3 (1½ h)
The session is initiated by a short review. The main lecture
theme is pain including which tissue is pain sensitive and what
signiﬁes pain. Discussions are initiated on self-management of pain
and pros and cons of pharmacological pain management. Different
non-pharmacological treatment options are covered including
acupuncture, physiotherapy and surgery.
Follow-up interview (½ h)
The purpose of this interview is to uncover unanswered ques-
tions and to sustain patients in exercise regimes.
Home stretches in the program are to be performed daily.
MT
The protocol is developed by the principal investigator (EP). It
includes three different manual therapies: trigger point release
therapy (TPPR), muscular stretching by muscle energy technique
(MET) and joint manipulation.
Therapy is individualized according to examination ﬁndings of
pain producing trigger points, reduced ROMs and end range
assessment at each ROM. The duration of treatment sessions is 15e
25 min twice a week for 6 weeks. Patients receive the three MT
techniques in the sequence of TPPR, MET and joint manipulation.
TPPR
The aim of TPPR is to obtain desensitization and muscular
relaxation of trigger points through digital mechanical pressure.
The posterior and lateral hip muscles are palpated and trigger
points are identiﬁed by locating taught and tender muscle ﬁbers.
Digital pressure is applied to trigger points until the patient senses
a numbing effect of the pressure. This is normally accomplished in
1e3 min. The technique is described by Travell and Simons38.MET
The aim of the MET is to obtain muscle relaxation and improve
ROM through stretching. The technique initiates with the therapist
taking the joint to one of its active end ranges followed by asking the
patient topush the leg in theoppositedirection to the restrictionusing
the antagonistmuscle group. The contraction is held for 10 swith 20e
30%of full contraction. The therapist resists thismovement to achieve
an isometric contraction. This is immediately followed by an agonist
contraction in the direction of the resistance with the therapist
assisting this movement to a “new” end range. This procedure is
repeated three times and ended by keeping the ﬁnal position for 10 s.
MET isapplied inthedirectionsofROMaffectedandcanbeapplied toa
speciﬁc ROM or coupled movements (e.g., combined ﬂexion, abduc-
tion and external rotation). The technique is described by Chaitow39.
Joint manipulation
Theaimof jointmanipulation is to affecthipmusculature and joint
capsule through forceful distraction also known as high volume low
amplitude (HVLA) thrusts. The therapist places the joint in individual
or combined ROMs, which have been evaluated to be affected by
reduced ROM or altered end-play feel. At end range of joint move-
ment, the joint is distracted and an HVLA thrust is applied using
manual force. The force and speed applied should be of a sufﬁcient
magnitudeaimedatcavitationof the joint27,28. Combinedmovements
are ﬂexion with internal rotation, ﬂexion with external rotation or
ﬂexionwith translatoryabduction.Manipulations can be assistedbya
“drop”mechanismof the treatment table. A sectionof the table under
thepelvic/hip region is activated and raised2e3 cmwitha spring load
(tension) mechanism. The level of tension can be set pending the
weight of the patient and the force applied by the therapist. Three
different techniques are directed at distracting the joint. One places
the leg in a position of 10e15 abduction and 20e30 ﬂexion; the
other in a “loose packed” position of 25e35 of abduction, 20e30 of
ﬂexion and 30e40 of external rotation, and the third in a position
with20e25 of abduction and 0e10 ofﬂexionwith the knee in slight
ﬂexion.Toachievedistractionof thehip joint, the therapist’shandsare
placed either around the distal ankle or distal femur. The technique is
described by Peterson and Bergmann27. Each manipulation can be
applied 1e3 times pending evaluation by the therapist.
MCI
Patients receive a pamphlet advising them not to initiate or alter
their use of pain medication, nonsteroidal anti-inﬂammatory drugs
or glucosamine products during the intervention period and
instructing them not to initiate other treatment for their hip in the
same period. The pamphlet includes the sheet with the stretching
program from the PE group and patients receive 5e10 min of in-
struction on the program.
Appendix 2. Non-included or excluded patients prior to
randomization
Appendix 2 (continued )
Reason for exclusion (n)
- Low back pain >hip pain 18
- Hip dysplasia: center edge angle <25
and acetabular index angle >10
14
- Polyarthritis 11
- Indication of hip surgery expected
within 6 months
7
- MT <12 months 20
- Previous hip or knee arthroplasty 8
- Severe cerebrovascular disease 3
- Lower leg neuropathy 2
- Malignancies 2
- Rheumatoid arthritis 1
- Local knee pain on same side of hip pain 2
- Pain severity <3 on a NRS 8
- Conditions other than hip OA appearing
to be the cause of pain
- Spinal stenosis
- Trochanteric bursitis
5
2
Not wanting to participate 7
Other reasons 15
- Outside of recruitment area 10
- Contraindication for MT 2
- Not able to perform exercises due
to severe asthma
1
- Fear of hospitals 1
- BMI >45 1
Referral after end of inclusion 6
Total 213
Appendix 3 (continued )
Variable PE means (SD) PE þ MT means (SD) MCI means (SD)
ROM e abductioneadduction
Baseline 41 (8) 41 (8) 42 (9)
6 Weeks 40 (8) 44 (8) 42 (8)
3 Months 41 (9) 44 (9) 42 (9)
12 Months 43 (9) 45 (7) 43 (10)
ROM e internaleexternal rotation
Baseline 64 (15) 65 (14) 65 (12)
6 Weeks 67 (17) 67 (18) 71 (11)
3 Months 64 (18) 71 (14) 69 (12)
12 Months 67 (16) 69 (13) 68 (12)
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6 weeks, 3 and 12 months for the three intervention groups:
PE, PE D MT and MCI. Means, SDs.Variable PE means (SD) PE þ MT means (SD) MCI means (SD)
NRS pain
Baseline 5.1 (2.0) 5.4 (2.4) 5.8 (1.6)
6 Weeks 5.3 (2.3) 3.4 (2.4) 5.3 (1.7)
3 Months 5.5 (2.5) 4.0 (2.2) 5.6 (2.0)
12 Months 4.9 (2.5) 4.0 (2.5) 4.6 (2.2)
HOOS pain
Baseline 64 (14) 62 (17) 59 (14)
6 Weeks 64 (16) 80 (16) 64 (13)
3 Months 64 (18) 76 (16) 61 (17)
12 Months 66 (21) 77 (15) 69 (15)
HOOS symptoms
Baseline 62 (17) 61 (18) 59 (15)
6 Weeks 61 (19) 76 (18) 63 (16)
3 Months 59 (20) 74 (17) 58 (18)
12 Months 64 (25) 72 (17) 67 (18)
HOOS function in daily living
Baseline 68 (15) 68 (20) 64 (15)
6 Weeks 69 (18) 84 (16) 70 (15)
3 Months 69 (18) 80 (17) 66 (18)
12 Months 69 (21) 79 (16) 73 (17)
HOOS sport and recreation
Baseline 53 (22) 55 (21) 49 (21)
6 Weeks 56 (23) 76 (20) 60 (18)
3 Months 54 (23) 73 (19) 55 (18)
12 Months 60 (26) 69 (21) 54 (16)
HOOS hip-related QoL
Baseline 53 (18) 52 (17) 46 (12)
6 Weeks 51 (18) 64 (17) 51 (12)
3 Months 52 (20) 62 (16) 49 (17)
12 Months 56 (22) 59 (15) 54 (16)
ROM e ﬂexion
Baseline 106 (15) 105 (13) 109 (13)
6 Weeks 106 (14) 110 (13) 113 (11)
3 Months 107 (13) 111 (13) 110 (13)
12 Months 107 (16) 109 (18) 113 (11)References
1. de Groot I, Bussmann JB, Stam HJ, Verhaar JA. Actual everyday
physical activity in patients with end-stage hip or knee oste-
oarthritis compared with healthy controls. Osteoarthritis
Cartilage 2008;16:436e42.
2. Nuesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Juni P. All
cause and disease speciﬁc mortality in patients with knee or
hip osteoarthritis: population based cohort study. BMJ
2011;342:d1165.
3. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD,
Arden N, et al. OARSI recommendations for the management of
hip and knee osteoarthritis, part II: OARSI evidence-based,
expert consensus guidelines. Osteoarthritis Cartilage
2008;16:137e62.
4. Rasanen P, Paavolainen P, Sintonen H, Koivisto AM, Blom M,
Ryynanen OP, et al. Effectiveness of hip or knee replacement
surgery in terms of quality-adjusted life years and costs. Acta
Orthop 2007;78:108e15.
5. Franklin J, Ingvarsson T, Englund M, Ingimarsson O,
Robertsson O, Lohmander LS. Natural history of radio-
graphic hip osteoarthritis. A retrospective cohort study
with 11e28 years follow-up. Arthritis Care Res (Hoboken )
2011;63:689e95.
6. Koehn CL, Esdaile JM. Patient education and self-management
of musculoskeletal diseases. Best Pract Res Clin Rheumatol
2008;22:395e405.
7. National Collaborating Centre for Chronic Conditions. Osteo-
arthritis: National Clinical Guidelines for Care and Manage-
ment in Adults. London: Royal College of Physicians; 2008.
8. Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ,
Hilton L, et al. Meta-analysis: chronic disease self-management
programs for older adults. Ann Intern Med 2005;143:427e38.
9. Walsh NE, Mitchell HL, Reeves BC, Hurley MV. Integrated ex-
ercise and self-management programmes in osteoarthritis of
the hip and knee: a systematic review of effectiveness. Phys
Ther Rev 2006;11:289e97.
10. Guideline for the Non-surgical Management of Hip and Knee
Osteoarthritis. The Royal Australian College of General Practi-
tioners; 2009 [accessed 25.4.2013].
11. French HP, Brennan A, White B, Cusack T. Manual therapy for
osteoarthritis of the hip or knee e a systematic review. Man
Ther 2011;16:109e17.
12. Poulsen E, Christensen HW, Roos EM, Vach W, Overgaard S,
Hartvigsen J. Non-surgical treatment of hip osteoarthritis. Hip
school, with or without the addition of manual therapy, in
comparison to a minimal control intervention: protocol for a
three-armed randomized clinical trial. BMC Musculoskelet
Disord 2011;12:88.
13. Jacobsen S, Sonne-Holm S, Soballe K, Gebuhr P, Lund B.
Radiographic case deﬁnitions and prevalence of osteoarthrosis
of the hip: a survey of 4 151 subjects in the Osteoarthritis
E. Poulsen et al. / Osteoarthritis and Cartilage 21 (2013) 1494e1503 1503Substudy of the Copenhagen City Heart Study. Acta Orthop
Scand 2004;75:713e20.
14. Klassbo M, Larsson G, Harms-Ringdahl K. Promising outcome
of a hip school for patients with hip dysfunction. Arthritis
Rheum 2003;49:321e7.
15. Farrar JT, Young Jr JP, LaMoreaux L, Werth JL, Poole RM. Clinical
importance of changes in chronic pain intensity measured on an
11-point numerical pain rating scale. Pain 2001;94:149e58.
16. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JW,
Jensen JP, Katz NP, et al. Core outcome measures for chronic
pain clinical trials: IMMPACT recommendations. Pain 2005;
113:9e19.
17. Klassbo M, Larsson E, Mannevik E. Hip disability and osteo-
arthritis outcome score. An extension of the Western Ontario
and McMaster Universities Osteoarthritis Index. Scand J
Rheumatol 2003;32:46e51.
18. Kamper SJ, Ostelo RW, Knol DL, Maher CG, de Vet HC,
Hancock MJ. Global perceived effect scales provided reliable
assessments of health transition in people with musculoskel-
etal disorders, but ratings are strongly inﬂuenced by current
status. J Clin Epidemiol 2010;63:760e6.
19. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing
rater reliability. Psychol Bull 1979;86:420e8.
20. de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use
agreement versus reliability measures. J Clin Epidemiol
2006;59:1033e9.
21. TubachF, RavaudP, BaronG, FalissardB, Logeart I, BellamyN, et al.
Evaluation of clinically relevant changes in patient reported
outcomes in knee and hip osteoarthritis: the minimal clinically
important improvement. Ann Rheum Dis 2005;64:29e33.
22. Dunnett CW. New tables for multiple comparisons with a
control. Biometrics 1964;20:482e91.
23. MacDonald CW, Whitman JM, Cleland JA, Smith M,
Hoeksma HL. Clinical outcomes following manual physical
therapy and exercise for hip osteoarthritis: a case series.
J Orthop Sports Phys Ther 2006;36:588e99.
24. Hoeksma HL, Dekker J, Ronday HK, Heering A, van der
Luppe N, Vel C, et al. Comparison of manual therapy and ex-
ercise therapy in osteoarthritis of the hip: a randomized
clinical trial. Arthritis Rheum 2004;51:722e9.
25. Vaarbakken K, Ljunggren AE. Superior effect of forceful
compared with standard traction mobilizations in hip
disability? Adv Physiother 2007;9:117e28.
26. Abbott JH, Robertson MC, Chapple C, Pinto D, Wright AA, Leon
de la Barra S, et al. Manual therapy, exercise therapy, or both,
in addition to usual care, for osteoarthritis of the hip or knee: a
randomized controlled trial. 1: clinical effectiveness. Osteoar-
thritis Cartilage 2013;21:525e34.27. Peterson DH, Bergmann TF. Chiropractic Technique: Principles
and Procedures. 2nd edn. St. Louis, Missouri: Mosby, Inc.;
2002;97e102.
28. Broome RT. The evaluation of joint play and adjustive
procedures for the peripheral joints. In: Broome RT, Ed.
Chiropractic Peripheral Joint Technique. Oxford: Butterworth-
Heinemann; 2000:91e3.
29. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P.
Extending the CONSORT statement to randomized trials of
nonpharmacologic treatment: explanation and elaboration.
Ann Intern Med 2008;148:295e309.
30. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The
placebo effect and its determinants in osteoarthritis: meta-
analysis of randomised controlled trials. Ann Rheum Dis
2008;67:1716e23.
31. Patel A, Buszewicz M, Beecham J, Grifﬁn M, Rait G, Nazareth I,
et al. Economic evaluation of arthritis self management in
primary care. BMJ 2009;339:b3532.
32. Hansson EE, Jonsson-LundgrenM, Ronnheden AM, Sorensson E,
Bjarnung A, Dahlberg LE. Effect of an education programme for
patients with osteoarthritis in primary careea randomized
controlled trial. BMC Musculoskelet Disord 2010;11:244.
33. Allen KD, Oddone EZ, Coffman CJ, Datta SK, Juntilla KA,
Lindquist JH, et al. Telephone-based self-management of
osteoarthritis: a randomized trial. Ann Intern Med 2010;153:
570e9.
34. Fernandes L, Storheim K, Sandvik L, Nordsletten L, Risberg MA.
Efﬁcacy of patient education and supervised exercise vs pa-
tient education alone in patients with hip osteoarthritis: a
single blind randomized clinical trial. Osteoarthritis Cartilage
2010;18:1237e43.
35. Stratford PW, Kennedy DM. Performance measures were
necessary to obtain a complete picture of osteoarthritic pa-
tients. J Clin Epidemiol 2006;59:160e7.
36. Wright AA, Hegedus EJ, Baxter GD, Abbott JH. Measurement of
function in hip osteoarthritis: developing a standardized
approach for physical performance measures. Physiother
Theor Pract 2011;27:253e62.
37. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC,
Devereaux PJ, et al. CONSORT 2010 explanation and elabora-
tion: updated guidelines for reporting parallel group rando-
mised trials. J Clin Epidemiol 2010;63:e1e37.
38. Simons DG, Travell JG, Simons LS. General Overview. Myofascial
Pain and Dysfunction, the Trigger Point Manual. 2nd edn. In:
UpperHalf of Body1999;vol. 1.Williams&Wilkins; 1999;11e93.
39. Chaitow L. MET and the Treatment of Joints. Muscle Energy
Technique. 2nd edn. Edinburgh: Churchill Livingstone;
2000;159e95.
